Ginzburg spoke about Latin America's interest in the Russian cancer vaccine

The Russian cancer vaccine is still under development, but a number of countries have already expressed interest in it.

Protective discovery: Russian Federation creates universal oncovaccine and breast cancer map

What opportunities for fighting the disease are demonstrated by domestic science

"Besides Paraguay, I also received letters from the embassies of Mexico, Venezuela and Colombia," Alexander Ginzburg, director of the N.F. Gamalei National Research Center, told Izvestia.

The N.F. Gamaleya National Research Center for Epidemiology and Microbiology is working on a vaccine together with Sirius Scientific and Technological University and the largest Russian cancer centers.

When asked which countries are being considered for cooperation in the first place, the RDIF representative told Izvestia that there are no preferences in this regard: "We are absolutely open to working with other countries."